- Title
- Patients with inflammatory bowel disease may have a transforming growth factor-Β-, interleukin (IL)-2-or IL-10-deficient state induced by intrinsic neutralizing antibodies
- Creators
- E. C Ebert - Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesA Panja - Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesK. M Das - Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesR Praveen - Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesX Geng - Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesC Rezac - Department of Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesM Bajpai - Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United States
- Publication Details
- Clinical and experimental immunology, Vol.155(1), pp.65-71
- Date published
- 2009
- Publisher
- Blackwell
- Academic Unit
- Medicine - Gastroenterology and Hepatology (RWJMS)
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031665741204646
Journal article
Patients with inflammatory bowel disease may have a transforming growth factor-Β-, interleukin (IL)-2-or IL-10-deficient state induced by intrinsic neutralizing antibodies
Clinical and experimental immunology, Vol.155(1), pp.65-71
2009
PMCID: PMC2665681
PMID: 19076830
Metrics
8 Record Views